The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer

By Sauven P.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2371-2374

Elsevier

Access to resources Recommend Favorite

Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 331-335

Spandidos Publications

Access to resources Recommend Favorite

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

By Espinosa E.   Morales S.   Borrega P.   Casas A.   Madroñal C.   Machengs I.   Illarramendi J.   Lizón J.   Moreno J.   Belón J.   Janáriz J.   Puente M.   Checa T.   Mel J.   González Barón M.  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 546-552

Springer Publishing Company

Access to resources Recommend Favorite

Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)

By Holm Neal   Abreo Fleurette   Johnson Lester   Li Benjamin   Chu Quyen  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 293-299

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant chemotherapy for locally advanced cervical cancer

By Timotheadou E.   Gore M.E.  

European Journal of Cancer, Vol. 39, Iss. 17, 2003-11 ,pp. : 2419-2421

Elsevier

Access to resources Recommend Favorite